Activities of ISO Working Group 18: Biological and Physical Retrospective Dosimetry
Abstract
Biological and physical retrospective dosimetry for ionizing radiation exposure is a rapidly growing field, and several methods for performing biological and physical retrospective dosimetry have been developed to provide absorbed dose estimates for individuals after occupational, accidental, intentional, and incidental exposures to ionizing radiation. In large-scale radiological/nuclear incidents, multiple retrospective dosimetry laboratories from several countries may be involved in providing timely dose estimates for effective medical management of several thousand exposed individuals. In such scenarios, the harmonization of methods among participating laboratories is crucial for consistency in data analysis, dose estimation, and medical decision-making. In this regard, ISO documents ensure that these practices are standardized globally across the laboratories by providing quality assurance and quality control documentation that guide laboratories in maintaining high-quality performance for consistency. With the intent of bringing standardization and harmonization of biological and physical retrospective dosimetry methodologies across national and international laboratories, the ISO working group 18 (WG18) was established under ISO/TC85/SC2 (Technical Committee 85, Subcommittee 2-Radiation Protection) in 1999. This manuscript summarizes some of the past, current, and future activities of WG18 on biological and physical retrospective dosimetry.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.